The Polish medtech company MedApp is investing in NRW as a business location. The company, which is traded on the stock exchanges in Warsaw and Frankfurt, has founded the subsidiary MedApp Germany for this purpose. "This is another important step in our international development. The foundation enables us to accelerate our expansion abroad and create shareholder value. MedApp Germany, based in Düsseldorf, will be our operational center in the German-speaking markets. Germany, Austria and Switzerland are very important markets for us and we want to make better use of their potential," emphasizes company CEO Krzysztof Mędrala.
MedApp was supported in its settlement by the consultants of NRW.Global Business. "We are delighted that MedApp has chosen NRW as the number 1 economic region in Germany as its location. Now we wish Krzysztof Mędrala a good start in the DACH region," announced NRW.Global Business as it welcomed the company.
The market for medical applications is strongly developed in Germany – MedApp wants to profit from this. The company offers technologies designed to facilitate the work of doctors and increase the comfort and safety of patients. "We have already been holding numerous trade talks in the German-speaking markets, which confirm the sales potential of our new subsidiary," adds Chairman Krzysztof Mędrala.
Initially, several employees from the Polish parent company will now be sent to work in the German-speaking markets. Local specialists from Germany will then be deployed in the near future.
